These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11684444)

  • 21. [Principle and biological applications of protein chip system].
    Ha KS
    Exp Mol Med; 2001 Apr; 33(1 Suppl):127-32. PubMed ID: 11708320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of human gastric cancer by transcriptome and proteome profiling].
    Li W; Liu BY; Zhang XQ; Yang YQ; Li JF; Tang KL; Zhang QH; Chen XH; Zhu ZG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):52-6. PubMed ID: 19145505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic and proteomic approaches for studying human cancer: prospects for true patient-tailored therapy.
    Carr KM; Rosenblatt K; Petricoin EF; Liotta LA
    Hum Genomics; 2004 Jan; 1(2):134-40. PubMed ID: 15601541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study.
    Wada Y; Azadi P; Costello CE; Dell A; Dwek RA; Geyer H; Geyer R; Kakehi K; Karlsson NG; Kato K; Kawasaki N; Khoo KH; Kim S; Kondo A; Lattova E; Mechref Y; Miyoshi E; Nakamura K; Narimatsu H; Novotny MV; Packer NH; Perreault H; Peter-Katalinic J; Pohlentz G; Reinhold VN; Rudd PM; Suzuki A; Taniguchi N
    Glycobiology; 2007 Apr; 17(4):411-22. PubMed ID: 17223647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival.
    Tang W; Zhou M; Dorsey TH; Prieto DA; Wang XW; Ruppin E; Veenstra TD; Ambs S
    Genome Med; 2018 Dec; 10(1):94. PubMed ID: 30501643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in the serum proteome profile during the development of ovarian cancer.
    Sun L; Li L; Li Z; Hong S; Yang Q; Qu X; Kong B
    Int J Oncol; 2014 Dec; 45(6):2495-501. PubMed ID: 25340615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microarrays as cancer keys: an array of possibilities.
    Mohr S; Leikauf GD; Keith G; Rihn BH
    J Clin Oncol; 2002 Jul; 20(14):3165-75. PubMed ID: 12118031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ongoing evolution of proteomics in malignancy.
    Dhamoon AS; Kohn EC; Azad NS
    Drug Discov Today; 2007 Sep; 12(17-18):700-8. PubMed ID: 17826682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface-assisted laser desorption/ionization mass spectrometry.
    Dattelbaum AM; Iyer S
    Expert Rev Proteomics; 2006 Feb; 3(1):153-61. PubMed ID: 16445359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of expression genomics for predicting treatment response in cancer.
    Chin KV; Alabanza L; Fujii K; Kudoh K; Kita T; Kikuchi Y; Selvanayagam ZE; Wong YF; Lin Y; Shih WC
    Ann N Y Acad Sci; 2005 Nov; 1058():186-95. PubMed ID: 16394136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells.
    Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ
    J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omics of cancer.
    Bhati A; Garg H; Gupta A; Chhabra H; Kumari A; Patel T
    Asian Pac J Cancer Prev; 2012; 13(9):4229-33. PubMed ID: 23167319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging role of genomics in endometriosis research.
    Taylor RN; Lundeen SG; Giudice LC
    Fertil Steril; 2002 Oct; 78(4):694-8. PubMed ID: 12372442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MALDI TOF mass spectrometry: an emerging platform for genomics and diagnostics.
    Leushner J
    Expert Rev Mol Diagn; 2001 May; 1(1):11-8. PubMed ID: 11901795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.
    Li R; Wang H; Bekele BN; Yin Z; Caraway NP; Katz RL; Stass SA; Jiang F
    Oncogene; 2006 Apr; 25(18):2628-35. PubMed ID: 16369491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of proteomic technologies to tumor analysis.
    Misek DE; Imafuku Y; Hanash SM
    Pharmacogenomics; 2004 Dec; 5(8):1129-37. PubMed ID: 15584879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix-assisted laser desorption/ionization imaging mass spectrometry: a promising technique for reproductive research.
    Lagarrigue M; Lavigne R; Guével B; Com E; Chaurand P; Pineau C
    Biol Reprod; 2012 Mar; 86(3):74. PubMed ID: 22156474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The genomics revolution and radiotherapy.
    West CM; Elliott RM; Burnet NG
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):470-80. PubMed ID: 17419040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mass spectrometric approaches to quantitative proteomics.
    Sechi S
    Contrib Nephrol; 2004; 141():59-78. PubMed ID: 14650225
    [No Abstract]   [Full Text] [Related]  

  • 40. Detection of matrix metalloproteinase active forms in complex proteomes: evaluation of affinity versus photoaffinity capture.
    Bregant S; Huillet C; Devel L; Dabert-Gay AS; Beau F; Thai R; Czarny B; Yiotakis A; Dive V
    J Proteome Res; 2009 May; 8(5):2484-94. PubMed ID: 19271733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.